Yuanyuan Zhang

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Histone Deacetylase

Renal Cell Carcinoma

Long Noncoding Rna

Top Venues

Journal of medicinal chemistry

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Zhenfei Zhou, Siqi Huang, Shijie Fan, Xueyuan Li, Chengyu Wang, Wanlin Yu, Daohai Du, Yuanyuan Zhang, Kaixian Chen, Wei Fu, Cheng Luo
Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor. Journal of medicinal chemistry 67 (14) (2024)
Zhenfei Zhou, Siqi Huang, Shijie Fan, Xueyuan Li, Chengyu Wang, Wanlin Yu, Daohai Du, Yuanyuan Zhang, Kaixian Chen, Wei Fu, Cheng Luo
Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor. Journal of medicinal chemistry (2024)
Zhenfei Zhou, Siqi Huang, Shijie Fan, Xueyuan Li, Chengyu Wang, Wanlin Yu, Daohai Du, Yuanyuan Zhang, Kaixian Chen, Wei Fu, Cheng Luo
Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor. Journal of medicinal chemistry 67 (14) (2024)
Zhenfei Zhou, Siqi Huang, Shijie Fan, Xueyuan Li, Chengyu Wang, Wanlin Yu, Daohai Du, Yuanyuan Zhang, Kaixian Chen, Wei Fu, Cheng Luo
Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor. Journal of medicinal chemistry 67 (14) (2024)
Hongru Tao, Chen Jin, Liyuan Zhou, Zhenzhong Deng, Xiao Li, Wenzhen Dang, Shijie Fan, Bing Li, Fei Ye, JunYan Lu, Xiang-Qian Kong, Chuanpeng Liu, Cheng Luo, Yuanyuan Zhang
PRMT1 inhibition activates the interferon pathway to potentiate antitumor immunity and enhance checkpoint blockade efficacy in melanoma. Cancer research (2023)
Jing Huang, Xiaobo Wang, Bing Li, Shiyu Shen, Ruina Wang, Hongru Tao, Junchi Hu, Jin Yu, Hualiang Jiang, Kaixian Chen, Cheng Luo, Yongjun Dang, Yuanyuan Zhang
L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression. Journal for immunotherapy of cancer 10 (6) (2022)
Daohai Du, Dandan Xu, Licheng Zhu, Giulia Stazi, Clemens Zwergel, Yanli Liu, Zhongyuan Luo, Yuanqing Li, Yuanyuan Zhang, Kongkai Zhu, Yiluan Ding, Jingqiu Liu, Shijie Fan, Kaiyan Zhao, Naixia Zhang, Xiangqian Kong, Hualiang Jiang, Kaixian Chen, Kehao Zhao, Sergio Valente, Jinrong Min, Wenhu Duan, Cheng Luo
Structure-Guided Development of Small-Molecule PRC2 Inhibitors Targeting EZH2-EED Interaction. Journal of medicinal chemistry 64 (12) (2021)
Hongru Tao, Jun Wang, Wen Chao Lu, Rukang Zhang, Yiqian Xie, Yu-Chih Liu, Rongfeng Liu, Liyan Yue, Kaixian Chen, Hualiang Jiang, Yuanyuan Zhang, Xiaohui Xu, Cheng Luo
Discovery of trisubstituted nicotinonitrile derivatives as novel human GCN5 inhibitors through AlphaScreen-based high throughput screening. RSC advances 9 (9) (2019)
Wei Chen, Hao Zhang, Zhifeng Chen, Hao Jiang, Liping Liao, Shijie Fan, Jing Xing, Yiqian Xie, Shijie Chen, Hong Ding, Kaixian Chen, Hualiang Jiang, Cheng Luo, Mingyue Zheng, Zhiyi Yao, Yiran Huang, Yuanyuan Zhang
Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma. Oncogenesis 7 (11) (2018)